Almoosa approves 2.5% cash dividend for Q3 2026
Almoosa Health Co.'s board of directors decided to pay a 2.5% cash dividend (SAR 0.25 per share) for the third quarter of 2026, according to a Tadawul statement.
|
Dividend Details (Q3 2026) |
|
|
Current Capital |
SAR 443.04 mln |
|
Number of Shares |
44.30 mln |
|
Total Dividend |
SAR 11.08 mln |
|
Percentage of Capital |
2.5% (SAR 0.25 per share) |
|
Record Date |
Nov. 12, 2026 |
|
Payment Date |
Nov. 26, 2026 |
|
Dividend Details (YTD) |
|
|
Total Dividend |
SAR 33.24 mln |
|
Percentage of Capital |
7.5% (SAR 0.75 per share) |
Dividend History (SAR/share) Corporate Actions
| Announcement | Ex-Dividend | Payment | Dividends (M Riyal) | Dividends * | Notes |
| 05/11/2026 | 12/11/2026 | 26/11/2026 | 11.08 | 0.25 | |
| 06/08/2026 | 13/08/2026 | 27/08/2026 | 11.08 | 0.25 | |
| 12/05/2026 | 17/05/2026 | 07/06/2026 | 11.08 | 0.25 | |
| 11/03/2026 | 29/03/2026 | 13/04/2026 | 15.51 | 0.35 | |
| 02/11/2025 | 06/11/2025 | 20/11/2025 | 15.51 | 0.35 | |
| 03/08/2025 | 07/08/2025 | 20/08/2025 | 15.51 | 0.35 | |
| 22/05/2025 | 25/05/2025 | 03/06/2025 | 11.08 | 0.25 | |
| 26/02/2025 | 20/05/2025 | 29/05/2025 | 44.30 | 1.00 |
Historical dividend per share adjusted for the effect of capital changes and bonus shares, if any
Dividend History
| Consolidated cash dividend | Cash dividend per share (SAR) | * The stock price at the beginning of the period (SAR) | Return on the base price |
|---|---|---|---|
| Last 3 Financial years | N/A | N/A | N/A |
| Last 5 Financial years | N/A | N/A | N/A |
| Last 10 Financial years | N/A | N/A | N/A |
Based on the beginning of the period (January 1 of the base year)
Comments {{getCommentCount()}}
Be the first to comment
{{Comments.indexOf(comment)+1}}
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.
Most Read
- Avalon Pharma CEO upbeat about Q4 performance
- Knauf raises stake in United Mining to 99.3%, plans delisting
- Bank AlJazira offers SAR-denominated T2 capital sukuk
- Arabian Mills CEO: Improved cost management drives Q3 profit growth; loans cut to SAR 638M
- Alsaif Gallery sees 0.3% rise in costs from power tariffs
Valuation Data (Latest Share Price)
| P/E (TTM) | 56.98 |
| Recurring P/E (TTM) | 26.06 |
| P/BV | 2.45 |
| Dividend Yield | 0.74 % |
| Market Cap. (M) | 4,695.80 |
| Return on Average Assets | 2.20 % |
| Return on Average Equity | 4.31 % |
Call Request
Comments Analysis: